Effects of a medication assistance program with medication therapy management on the health of renal transplant recipients (Q51468070)

5 April 2018

title

Effects of a medication assistance program with medication therapy management on the health of renal transplant recipients (English)

1 reference

5 April 2018

author name string

Marie A Chisholm

series ordinal

1 reference

5 April 2018

Christina A Spivey

series ordinal

1 reference

5 April 2018

Laura L Mulloy

series ordinal

1 reference

5 April 2018

publication date

1 July 2007

1 reference

5 April 2018

American Journal of Health-System Pharmacy

published in

1 reference

5 April 2018

volume

1 reference

5 April 2018

issue

1 reference

5 April 2018

page(s)

1506-1512

1 reference

5 April 2018

Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Medication compliance following renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Five preventable causes of kidney graft loss in the 1990s: a single-center analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Assistance programs available for medications commonly used in transplant patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Pharmacist-facilitated enrollment in medication assistance programs in a private ambulatory care clinic.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Medication access through patient assistance programs

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Medication nonadherence and its relation to financial restriction.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Outpatient medication assistance program in a rural setting.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Medication use patterns and health outcomes among patients using a subsidized prescription drug program

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

The Banff 97 working classification of renal allograft pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Factors predicting long-term graft survival after kidney transplantation: multicenter study in Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Predictors of cardiovascular events and associated mortality of kidney transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Hypertension after kidney transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Hypertension, antihypertensive agents and outcomes following renal transplantation.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Predictors of cardiovascular events and associated mortality within two years of kidney transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Patient survival after renal transplantation III: the effects of statins

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Improved long-term outcomes after renal transplantation associated with blood pressure control

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Posttransplant diabetes mellitus: Impact of good blood glucose regulation on renal transplant recipient outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Glycaemic control and graft loss following renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

Predictors of quality of life at 5 to 6 years after heart transplantation.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

The first report from the patient outcomes registry for transplant effects on life (PORTEL): differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060634

31 March 2020

Identifiers

DOI

10.2146/AJHP060634

1 reference

5 April 2018

1 reference

5 April 2018